Fibrin membrane pupillary-block glaucoma after uneventful cataract surgery treated with intracameral tissue plasminogen activator: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Fibrin membrane pupillary-block glaucoma after uneventful cataract surgery treated with intracameral tissue plasminogen activator: a case report ; volume:12 ; number:1 ; day:20 ; month:3 ; year:2012 ; pages:1-4 ; date:12.2012
BMC ophthalmology ; 12, Heft 1 (20.3.2012), 1-4, 12.2012
- Creator
-
Yoshino, Hideaki
- Contributor
-
Seki, Masaaki
Ueda, Jun
Yoshino, Takaiko
Fukuchi, Takeo
Abe, Haruki
SpringerLink (Online service)
- DOI
-
10.1186/1471-2415-12-3
- URN
-
urn:nbn:de:1111-201604145825
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yoshino, Hideaki
- Seki, Masaaki
- Ueda, Jun
- Yoshino, Takaiko
- Fukuchi, Takeo
- Abe, Haruki
- SpringerLink (Online service)
Other Objects (12)
Synthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Mydriasert pupillary dilation for cataract surgery: an economic and clinical study
Urokinase-type plasminogen activator receptor in vascular calcification
Influence of delivery on plasminogen activator inhibitor activity
Plasminogen Activator Release by Oral Contraceptives and Exercise
Isolation and Properties of Human Vascular Plasminogen Activator
Purification and Some Properties of Tissue Plasminogen Activator
Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
Synthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Mydriasert pupillary dilation for cataract surgery: an economic and clinical study
Urokinase-type plasminogen activator receptor in vascular calcification
Influence of delivery on plasminogen activator inhibitor activity
Plasminogen Activator Release by Oral Contraceptives and Exercise
Isolation and Properties of Human Vascular Plasminogen Activator
Purification and Some Properties of Tissue Plasminogen Activator
Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
Synthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Mydriasert pupillary dilation for cataract surgery: an economic and clinical study
Urokinase-type plasminogen activator receptor in vascular calcification
Influence of delivery on plasminogen activator inhibitor activity
Plasminogen Activator Release by Oral Contraceptives and Exercise
Isolation and Properties of Human Vascular Plasminogen Activator
Purification and Some Properties of Tissue Plasminogen Activator